Request Trial
16 April 2026NewsCareers

Baker McKenzie strengthens IP bench with new German lead

Fresh hire, who will take up his new role in May, brings years of expertise in pharmaceuticals and artificial intelligence to the firm’s Frankfurt practice.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Quantum and photonics tech licensing expert joins EIP
18 June 2026   With more than 25 years of experience as a commercial and IP lawyer, the firm’s new partner previously led the legal function at a pioneering UK company.
Careers
Ex-Simmons head of IP joins Carpmaels & Ransford
15 June 2026   Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech practice and beefing up its IP disputes work.
Careers
MoFo bags IP trial duo with 50 years’ combined experience
11 June 2026   The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.


Editor's picks

Hikma v Amarin: Six takeaways from the pivotal ruling
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

Editor's picks

Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026

More features

US life sciences damages averaged $33.5m between 2019-2025
Quantum and photonics tech licensing expert joins EIP
Court upholds $83m sequencing verdict and sets royalty rate
Exclusive: ‘Cultural differences are an asset’ at the UPC
Amgen and subsidiary dealt $20m blow over rodent antibody tech
Ex-Simmons head of IP joins Carpmaels & Ransford
Moderna: BioNTech is claiming work ‘it never did’
Siemens ordered to recall mammography device across European countries